![](/img/cover-not-exists.png)
Anti-CTLA-4 therapy broadens the melanoma-reactive CD8+ T cell response
Kvistborg, P., Philips, D., Kelderman, S., Hageman, L., Ottensmeier, C., Joseph-Pietras, D., Welters, M. J. P., van der Burg, S., Kapiteijn, E., Michielin, O., Romano, E., Linnemann, C., Speiser, D.,Volume:
6
Language:
english
Journal:
Science Translational Medicine
DOI:
10.1126/scitranslmed.3008918
Date:
September, 2014
File:
PDF, 386 KB
english, 2014